Valuation : LifeMD, Inc.

Market Cap 148M 127M 119M 109M 204M 13.99B 206M 1.41B 550M 7.15B 556M 544M 23.02B P/E 2026 *
-5.92x
P/E 2027 * -58.1x
Enterprise Value 148M 127M 119M 109M 204M 13.99B 206M 1.41B 550M 7.15B 556M 544M 23.02B EV / Sales 2026 *
0.71x
EV / Sales 2027 * 0.6x
Free-Float
85.13%
Yield 2026 *
-
Yield 2027 * -
1 day+0.16%
1 week-5.37%
Current month-0.16%
1 month-17.29%
3 months-32.35%
6 months+6.01%
Current year-9.53%
1 week 3.02
Extreme 3.025
3.3
1 month 3
Extreme 3
4.02
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
7.32
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 01/08/2025
Director of Finance/CFO 57 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 04/09/2014
Chairman 43 11/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
11/8/26 Free

Director

35,000 0.0724%
11/8/26 Free

Director

35,000 0.0724%
11/8/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-5.37%-49.43%-33.66% 148M
+0.07%-0.06%+4.06%+28.25% 45.45B
+0.16%-6.45%-41.39%+136.71% 12.92B
+1.54%+2.68%-11.93%+67.32% 5.74B
-0.74%+3.01%+58.41% - 4.35B
+1.38%+3.95% - - 2.09B
+1.14%+5.24%+7.13%-40.63% 1.58B
-1.34%-1.68%-34.67% - 1.1B
-4.29%-1.38%+52.06%+60.80% 992M
+0.69%-0.77%+30.53%+151.47% 1.01B
Average -0.13%+0.90%+1.64%+52.89% 7.54B
Weighted average by Cap. +0.13%+8.17%-1.59%+52.77%

Financials

2026 *2027 *
Net sales 208M 179M 168M 153M 286M 19.62B 288M 1.98B 772M 10.03B 779M 762M 32.29B 245M 211M 198M 181M 338M 23.16B 340M 2.34B 911M 11.84B 920M 900M 38.12B
Net income -24.83M -21.36M -20.05M -18.34M -34.23M -2.35B -34.5M -237M -92.35M -1.2B -93.23M -91.2M -3.86B -2.68M -2.3M -2.16M -1.98M -3.69M -253M -3.72M -25.55M -9.95M -129M -10.05M -9.83M -416M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
04/09/26 US$3.075 +0.16% 373,607
02/09/26 US$3.070 -0.97% 731,008
01/09/26 US$3.100 +0.32% 748,952
31/08/26 US$3.090 -1.59% 697,280
28/08/26 US$3.140 -3.68% 466,443
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.070USD
Average target price
8.125USD
Spread / Average Target
+164.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock